170490 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants; Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
METHODS FOR TREATING ENDOMETRIAL AND OVARIAN HYPERPROLIFERATIVE DISORDERS
#2COMPOSITIONS AND METHODS RELATED TO INHIBITION OF ADENOMAS AND ADENOCARCINOMAS
#3BIOMARKERS FOR ALLERGEN IMMUNOTHERAPY
#4Integrin Alpha10 Antibody
#5A4B1 BINDING APTAMERS
#6PROTEOMIC SAMPLE INVESTIGATION METHOD FOR DIAGNOSING RHABDOMYOLYSIS AND KITS FOR IMPLEMENTING SAME
#7Active Alpha-5-Beta-1 Integrin As A Biomarker For Enhancing Tumor Treatment Efficacy
#8METHODS AND ASSAYS WITH POPULATIONS OF CELLS
#9ANTI-VLA-4 RELATED ASSAYS
#10THERAPEUTICALLY ACTIVE CELLS AND EXOSOMES
#11Materials and Methods for Eliciting Targeted Antibody Responses In Vivo
#12Administration of agents for the treatment of inflammation
#13Anti-VLA-4 related assays
#14Anti-integrin β1 antibody compositions and methods of use thereof
#15Materials and Methods for Eliciting Targeted Antibody Responses In Vivo
#16Anti-VLA-4 related assays
#17ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION
#18Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
#19Reconstituted nipple skin model
#20Monoclonal antibody capable of binding integrin alpha 10 beta 1
#21Anti-VLA-4 related assays
#22Anti-alphavbeta1 integrin inhibitors and methods of use
#23METHOD OF DIAGNOSING SEPSIS OR SEPSIS RISK
#24PEPTIDE OR PEPTIDE COMPLEX BINDING TO ALPHA2 INTEGRIN AND METHODS AND USES INVOLVING THE SAME
#25Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
#26NON-B-LINEAGE CELLS CAPABLE OF PRODUCING ANTIBODY
#27Isolated cardiac stem cells and methods of their use
#28Compositions of cardiomyocyte subpopulations
#29METHOD FOR INTEGRIN LIGAND DISCOVERY
#30Use of integrin beta subunits in the diagnosis of venous thromboembolism
#31PHARMACEUTICAL COMPOSITION AND METHOD FOR IDENTIFYING A CANCEROUS AND/OR AN INFLAMMATORY DISEASE IN A PATIENT
#32Cell-surface signatures for isolating neurons from cell cultures derived from pluripotent stem cells
#33Anti-integrin β1 antibody compositions and methods of use thereof
#34Monoclonal antibody capable of binding integrin alpha 10 beta 1
#35CD49F promoting proliferation, multipotency and reprogramming of adult stem cells through PI3K/AKT/GSK3 pathway
#36Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin
#37Method for integrin ligand discovery
#38Sepsis test
#39Anti-VLA-4 related assays
#40VLA-4 AS A BIOMARKER FOR PROGNOSIS AND TARGET FOR THERAPY IN DUCHENNE MUSCULAR DYSTROPHY
#41Integrin alpha 8-beta 1-specific monoclonal antibody
#42Method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin alpha 5
#43Monoclonal antibody capable of binding integrin alpha 10 beta 1
#44METHODS FOR PREDICTING AUTOIMMUNE DISEASE RISK
#45PHARMACEUTICAL COMPOSITION AND METHOD FOR IDENTIFYING A CANCEROUS AND/OR AN INFLAMMATORY DISEASE IN A PATIENT
#46Preventing and treating sepsis
#47METHODS OF SELECTION OF CELLS FOR TRANSPLANTATION
#48Anti-alpha2 integrin antibodies and their uses
#49Use of antagonists of the interaction between HIV GP120 and A4B7 integrin
#50ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION
#51Method for isolating smooth muscle stem cells
#52Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy
#53Method of Screening Drug with the Use of 67 kDa Laminin Receptor and Drug Obtained Thereby
#54NOVEL RECEPTOR FOR CD40L AND USES THEREOF
#55Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
#56Sepsis Test
#57Collagen Receptor I-Domain Binding Modulators
#58Monoclonal antibody capable of binding integrin alpha 10 beta 1
#59Suppression of sPLA2-integrin binding for treating an inflammatory condition
#60BETA 1 INTEGRIN ACTIVATION AS A MARKER FOR ASTHMA
#61Collagen Receptor I-Domain Binding Modulators
#62Methods of Evaluating Efficacy of an Immune Response by Assesing Alpha-1 Integrin Expression
#63REAGENT FOR DETERMINING LAMININ 5 ANTIGEN IN BIOLOGICAL SAMPLE AND ASSAY METHOD
#64Genetic characterization and prognostic significance of cancer stem cells in cancer
#65Anti-α2 integrin antibodies and their uses
#66Administration of agents for the treatment of inflammation
#67Method of screening drug with the use of 67 kDa laminin receptor and drug obtained thereby
#68Monoclonal antibody capable of binding integrin alpha 10 beta 1
#69Humanized anti-VLA4 immunoglobulins
#70Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
#71Diagnosis of pancreatic cancer by using pancreatic targets
#72Methods for inhibiting angiogenesis